Better cervical cancer screening and treatment access for women with HIV in Kenya
Enhanced Cervical Cancer Screening Adoption and Treatment Linkage for HIV positive Women in Kenya (eCASCADE-Kenya)
This program works to improve cervical cancer screening and help women living with HIV in Kenya get linked quickly to treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11172250 on NIH RePORTER |
What this research studies
If you are a woman living with HIV in Kenya, this program aims to bring more and earlier cervical cancer screening to clinics you already visit. It will try practical ways to make sure screening results lead to timely follow-up and treatment, while training local health workers and researchers. The center brings together partners at Emory, Kenyatta National Hospital, University of Washington, and Queen’s University to run two research projects plus a research capacity-building core with community and government engagement. The goal is to make screening and treatment services more available, reliable, and sustainable where you live.
Who could benefit from this research
Good fit: Women living with HIV in Kenya who are in the recommended age range for cervical cancer screening and receive care at participating clinics.
Not a fit: People who do not live in Kenya, do not have HIV, or already have late-stage untreatable cancer are unlikely to benefit directly.
Why it matters
Potential benefit: Could lead to earlier detection and faster treatment for cervical cancer in women with HIV, lowering preventable illness and deaths.
How similar studies have performed: Screening and early treatment for cervical cancer are proven to save lives, but implementing sustainable screening and linkage programs in sub-Saharan Africa has had mixed success, so this center expands on prior pilot efforts.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Kosgei, Rose Jepchumba — Emory University
- Study coordinator: Kosgei, Rose Jepchumba
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.